Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice
Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma Intervention: Drug: Ibrutinib Sponsors: The First Affiliated Hospital with Nanjing Medical University; Xian-Janssen Pharmaceutical Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials